However, emerging evidence suggested the pro-tumor roles of the cGAS-STING pathway, from tumor initiation and development, to metastasis [69–72] (Fig. 4), which makes the application of STING agonists in the clinic remains a lot to challenge. Here, STING1 is linked to neoplasm.